 | Up a level |
Conway, GS; Szarras-Czapnik, M; Racz, K; Keller, Anita; Chanson, P; Tauber, M; Zacharin, M; 1369, GHD to GHDA Transition Study Group (2009). Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. European journal of endocrinology, 160(6), pp. 899-907. Bristol: BioScientifica Ltd. 10.1530/EJE-08-0436
